Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
The Argus II Retinal Prosthesis System, or "Bionic Eye," is a breakthrough for patients with late-stage Retinitis Pigmentosa (RP). By using a camera-mounted pair of glasses to send electrical signals to the retina, the system stimulates the remaining optic nerve. It remains the gold standard for restoring functional artificial vision.
read more about argus ii success rate ...Clinical data indicates that 89 percent of Argus II recipients achieve a significant improvement in functional visual tasks. While the vision is artificial (appearing as flashes of light called phosphenes), statistics show that 80 percent of patients can identify the location of a high-contrast object with the system turned on.
The primary success of the "Bionic Eye" is mobility. Data reveals that 56 percent of patients show a measurable improvement in their ability to follow a sidewalk or find a doorway without a cane. Orientation and mobility scores for Argus II users are 3.5 times higher than their baseline scores when the system is off.
It is important to manage expectations: Argus II does not restore 20/20 vision. Statistics show that the majority of patients achieve an equivalent visual acuity of approximately 20/1200. While this is still legally blind, it is a massive gain for patients who previously had "no light perception."
The surgical success rate for implantation is remarkably high at 98 percent. The procedure is performed as an outpatient vitrectomy. Safety data indicates that serious complications, such as retinal detachment, occur in less than 5 percent of cases. Most failures are due to the device being unable to anchor to a diseased retina.
Long-term reliability is a key factor. Data shows that 60 percent of devices remain fully functional after 10 years. However, about 15 percent of patients experience a reduction in effectiveness over time, likely due to the natural progression of the underlying retinal disease or the buildup of microscopic scar tissue.
In 2026, you cannot see fine details like a person's eye color. You would see a person as a "shimmering shape" or a collection of light flashes. However, 80% of users report they can tell where a person is standing and whether they are moving toward them, which is a huge help in social settings.
No. You control the system via a battery pack. Most users use it for 4 to 6 hours a day for specific tasks like walking in an unfamiliar building. When you turn it off, you return to your baseline vision. It's similar to how a person with a cochlear implant uses their hearing aid.
The surgery is done under general anesthesia, so you don't feel anything. During recovery, most patients report pressure or grittiness for about 2 weeks. The biggest part of the process is the rehabilitation, where you spend 3 to 6 months training your brain to understand the flashes of light.
Consult a retina specialist or a low-vision rehabilitation expert if your remaining vision has dropped to "bare light perception." Seek immediate care if you already have an implant and notice a sudden loss of "phosphenes" (the flashes of light), as this could indicate a technical failure of the electrode array or a new retinal hemorrhage that needs surgical repair.